Toenail fungus is a notoriously difficult foe. Current treatment options include home remedies, topical therapies, oral medication, and laser treatment – but each nail fungus solution has its own set of caveats. Topical treatments and home cures are notoriously ineffective; oral medication carries the greatest risk of harm to the patient, and laser treatment (not covered by insurance) is expensive. Jublia is a new antifungal option that will hit the market later this year.
What Is Jublia?
Jublia® (efinaconazole 10% topical solution) is an FDA-approved topical antifungal developed to treat toenail fungus. The bottle comes with a built-in applicator for easy daily use. Unlike other topical remedies that can be messy and require patients to remove excess product, Jublia dries quickly. It also has an excellent safety profile, without the drug interaction and liver damage concerns of oral medications for toenail fungus. Marketing should begin later this year, according to manufacturer Valeant.
New Topical Nail Fungus Treatment Research
Prior to FDA approval, two pivotal studies of 1,655 onychomycosis sufferers were published in the Journal of the American Academy of Dermatology. The first study found that 17.8% of subjects were completely cured at Week 52 (compared to 3.3% of the subjects treated with a placebo). The second study reported that 15.2% of subjects were cured (compared to 5.5% of the placebo). A few patients encountered pain, ingrown toenails, dermatitis, or the appearance of small fluid-filled sacs at the application site. While these cure rates may not sound impressive, they are better than the topical solutions currently on the market.
What Foot Doctors Say About Jublia
“To date, ciclopirox nail lacquer (Penlac) is the only topical treatment approved by the Food and Drug Administration for the treatment of onychomycosis in the United States,” wrote Dr. Richard Pollak, DPM in Podiatry Today. “Unfortunately, ciclopirox nail lacquer has reported complete cure rates of 5.5-8.5%, requires frequent nail debridement and patients have to use alcohol to remove excess buildup of lacquer from the ventral aspect of the nail plate to avoid additional infection.” He adds that podiatrists are often hesitant to recommend topical solutions because the effectiveness rates are so low, but patients have indicated that they would like a safe, easy-to-use topical nail fungus treatment. Perhaps the active ingredient in Jublia, efinaconazole, represents the next generation of topical therapies for at-risk patients.
Prevent The Recurrence Of Toenail Fungus With UV Light
Once you have been treated for toenail fungus, take the next step to limit your exposure to fungal spores and pathogens by purchasing the SteriShoe UV shoe sanitizer. To use our device, simply insert an ultraviolet light wand into each shoe, cover the shoes with the provided shoe bags, click the “on” switch, and leave it to sit for 45 minutes. The device will automatically turn itself off when the cycle is done. Research shows up to 99.9% of the fungi, bacteria and viruses inside the shoes will be eradicated, given this treatment. Given these findings, it’s no wonder podiatrists and the American Podiatric Medical Association recommend it. Try the SteriShoe UV shoe sanitizer risk-free for 30 days!